Skip to main content
OpenTrials
Completed

NCT Number: NCT04669314

Surgical Approach in Liver Hemangiomas

Operations performed for liver hemangioma between January 2017 and December 2018 will be retrospectively analyzed.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hemangioma Liver Hemangioma Neoplasms Neoplasms by Histologic Type Neoplasms, Vascular Tissue

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Ankara University Ibni Sina Hospital

Ankara, Turkey (Türkiye)

About this study

Operations performed for liver hemangioma at Ankara University Hospitals will be retrospectively analyzed. Patient and disease characteristics including demographics, laboratory tests, imaging studies, type of surgical approach and outcomes including postoperative laboratory tests, record of complications, duration of hospital stay will be reviewed. Complications were classified according to Clavien-Dindo classification. The patients were informed about the surgeries in advance and their informed consents about surgeries and data collection for scientific purposes were obtained. Datafile will be anonymized before analysis and original file will be destroyed. Outcomes such as complications, hospital stay, blood transfusion and mortality will be compared between groups created according to type of surgery, lesion size, preoperative laboratory values and demographic features. Variables for prediction of better outcomes are expected to be discovered.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients underwent surgery for liver hemangioma

Exclusion criteria

  • Cases lacking of more than 20% of critical data

Treatment and study plan

Liver resection or enucleation for liver hemangioma

Procedure

Operations in which the hemangioma is selectively removed from the liver parenchyma border are named enucleation, and the operations in which the hemangioma is removed anatomically or non-anatomically with some liver parenchyma surrounding it are named liver resection

Primary outcomes

  1. Complications

    Time frame: Complications reported within 3 months after surgery will be evaluated within 15 days after completion of data collection

    Complications after surgery for hemangioma will be collected from records and and will be classified according to 'The Clavien-Dindo Classification of Surgical Complications'. The classification grades are ranging between Grade 1(better) which indicates minor deviation from normal postoperative course and Grade 5 (worst) which means death as a complication.

Secondary outcomes

  1. Hospital stay

    Time frame: Hospital stay starting with operation and ends with discharge will be compared within 15 days after completion of data collection

    Length of hospital stay postoperatively

  2. Transfusion

    Time frame: Erythrocyte transfusion during surgery will be analyzed within 15 days after completion of data collection

    Rate of erythrocyte transfusion

Sponsors and collaborators

Lead sponsor

Ankara University

Other

Registry information

Official study title

Surgical Approach in Liver Hemangiomas With Special Emphasis on Lesion Diameter and Type of Surgery

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Dec 16, 2020
Registry last updated
Dec 16, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.